
Get exclusive money-saving offers and guides
Straight to your inbox
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Livongo Health, Inc is a medical devices business with stocks listed in the US. Livongo Health shares (LVGO) are listed on the NASDAQ and all prices are listed in US Dollars. Here's how to invest if you're based in Australia.
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
52-week range | US$18.76 - US$150 |
---|---|
50-day moving average | US$141.7294 |
200-day moving average | US$109.5777 |
Target price | US$122.13 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | US$-2.95 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing Livongo Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Livongo Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Livongo Health's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.9675. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Livongo Health's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Revenue TTM | US$317.2 million |
---|---|
Gross profit TTM | US$124 million |
Return on assets TTM | -1.13% |
Return on equity TTM | 0% |
Profit margin | -13.07% |
Book value | 5.308 |
Market capitalisation | US$14.2 billion |
TTM: trailing 12 months
There are currently 8.2 million Livongo Health shares held short by investors – that's known as Livongo Health's "short interest". This figure is 17.8% down from 10.0 million last month.
There are a few different ways that this level of interest in shorting Livongo Health shares can be evaluated.
Livongo Health's "short interest ratio" (SIR) is the quantity of Livongo Health shares currently shorted divided by the average quantity of Livongo Health shares traded daily (recently around 1.9 million). Livongo Health's SIR currently stands at 4.27. In other words for every 100,000 Livongo Health shares traded daily on the market, roughly 4270 shares are currently held short.
However Livongo Health's short interest can also be evaluated against the total number of Livongo Health shares, or, against the total number of tradable Livongo Health shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Livongo Health's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Livongo Health shares in existence, roughly 80 shares are currently held short) or 0.1807% of the tradable shares (for every 100,000 tradable Livongo Health shares, roughly 181 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Livongo Health.
Find out more about how you can short Livongo Health stock.
We're not expecting Livongo Health to pay a dividend over the next 12 months.
Livongo Health, Inc. provides an integrated suite of solutions for the healthcare industry in North America. Its solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications. Its products include Livongo for diabetes, Livongo for hypertension, Livongo for prediabetes and weight management, and Livongo for behavioral health by myStrength. The company was formerly known as EosHealth, Inc. and changed its name to Livongo Health, Inc. in 2014. Livongo Health, Inc. was incorporated in 2008 and is headquartered in Mountain View, California. As of October 30, 2020, Livongo Health, Inc. operates as a subsidiary of Teladoc Health, Inc.
From the best sheets for summer to the most luxurious threads, these are the seven best bed sheets you can get in Australia right now.
Everything we know about the Bumble IPO, plus information on how to buy in.
Steps to owning and managing MicroStrategy shares.
Everything we know about the Kuaishou IPO, plus information on how to buy in.
Everything we know about the Coinbase IPO, plus information on how to buy in.
Everything we know about the Databricks IPO, plus information on how to buy in.
Steps to owning and managing Ligand Pharmaceuticals shares.
You can't access Robinhood in Australia, so here are five low-cost alternatives to trade US stocks.
Reddit has long been home to a huge retail investing community called WallStreetBets. Find out how to get the latest Reddit-tipped stocks here.
Steps to owning and managing Koss shares.